Phase II trial of irinotecan and cisplatin combination as first-line chemotherapy in patients with advanced esophageal squamous-cell carcinoma: An interim report

被引：1
作者：
Zhang, X.
Shen, L.
Li, J.
Li, Y.
Zhou, J.
Lu, Z.
Lu, M.
机构：
[1] Peking Univ, Canc Hosp & Inst, Dept Gastrointestinal Oncol, Beijing 100871, Peoples R China
[2] Peking Univ, Canc Hosp, Dept Gastrointestinal Oncol, Beijing 100871, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 04期
关键词：
D O I：
10.1200/jco.2011.29.4_suppl.137
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
137
引用
收藏
页数：1
相关论文
共 50 条
[41]   Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer [J].
G. Quintero-Aldana ;
M. Jorge ;
C. Grande ;
M. Salgado ;
E. Gallardo ;
S. Varela ;
C. López ;
M. J. Villanueva ;
A. Fernández ;
E. Alvarez ;
P. González ;
J. Castellanos ;
J. Casal ;
R. López ;
B. Campos Balea .
Cancer Chemotherapy and Pharmacology, 2015, 76 :731-737
[42]   A phase II trial of weekly irinotecan and cisplatin for chemotherapy-naive patients with metastatic or recurrent squamous cell carcinoma of the esophagus [J].
Lee, Dae Ho ;
Han, Ji-Youn ;
Yu, Sun Young ;
Lim, Eun Ju ;
Kim, Hyae Young ;
Kim, Heung Tae ;
Lee, Jin Soo ;
Kim, Noe Kyeong .
ANNALS OF ONCOLOGY, 2006, 17 :320-320
[43]   A phase II study of S-1 and irinotecan combination chemotherapy in patients with advanced gastric cancer as a first-line therapy [J].
Ryoo, B. Y. ;
Kang, H. J. ;
Yang, S. H. ;
Cho, S. H. ;
Oh, S. J. ;
Lee, M. H. ;
Song, E. K. ;
Chung, H. C. .
EJC SUPPLEMENTS, 2007, 5 (04) :274-274
[44]   Polymeric Micellar Paclitaxel Plus Cisplatin Combined With Tislelizumab as the First-Line Treatment of Advanced Unresectable Esophageal Squamous Cell Carcinoma: A Phase II Study [J].
Li, Xiaoyou ;
Shi, Jiamin ;
Zhu, Jinghua ;
Zhu, Jingni ;
Yan, Fei ;
Liu, Delin ;
Cao, Guochun .
THORACIC CANCER, 2025, 16 (07)
[45]   A phase II trial of gefitinib in combination with capecitabine and oxaliplatin as first-line chemotherapy in patients with advanced colorectal cancer [J].
Gelibter, Alain J. ;
Gamucci, Teresa ;
Pollera, Camillo F. ;
Di Costanzo, Francesco ;
Nuzzo, Carmen ;
Gabriele, Angela ;
Signorelli, Carlo ;
Gasperoni, Silvia ;
Ferraresi, Virginia ;
Giannarelli, Diana ;
Cognetti, Francesco ;
Zeuli, Massimo .
CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (09) :2117-2123
[46]   Erratum to: Phase II trial of biweekly docetaxel, cisplatin, and 5-fluorouracil chemotherapy for advanced esophageal squamous cell carcinoma [J].
Yoshihiro Tanaka ;
Kazuhiro Yoshida ;
Atsuko Yamada ;
Toshiyuki Tanahashi ;
Naoki Okumura ;
Nobuhisa Matsuhashi ;
Kazuya Yamaguchi ;
Tatsuhiko Miyazaki .
Cancer Chemotherapy and Pharmacology, 2016, 77 :1153-1155
[47]   Combination of docetaxel, cisplatin, and capecitabine (DCX) as a first-line chemotherapy in patients with metastatic gastric carcinoma: A phase II study [J].
Narimanov, Mekhty ;
Tryakin, Alexey ;
Bazin, Igor ;
Kanagavel, Dheepak ;
Tjulandin, Sergei .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[48]   The efficacy and toxicities of combined lobaplatin with paclitaxel as a first-line chemotherapy for advanced esophageal squamous cell carcinoma [J].
Chen, Ming-Qiu ;
Chen, Cheng ;
Lu, Hai-Jie ;
Xu, Ben-Hua .
JOURNAL OF THORACIC DISEASE, 2015, 7 (10) :1749-1755
[49]   Prospective phase II trial of a combination of gemcitabine, cisplatin and UFT as first-line treatment in patients with advanced, unresectable, non-small cell lung carcinoma [J].
Jin, S. S. ;
Min, Y. ;
Kim, H. ;
Ahn, J. ;
Jegal, Y. ;
Seo, K. ;
Park, C. ;
Shin, J. ;
Cha, H. ;
Kwon, W. ;
Park, J. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[50]   Nivolumab combination therapy as first-line treatments for unresectable, advanced or metastatic esophageal squamous cell carcinoma [J].
Rogers, Jane E. ;
Yamashita, Kohei ;
Sewastjanow-Silva, Matheus ;
Rosa Vicentini, Ernesto ;
Waters, Rebecca ;
Ajani, Jaffer A. .
EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (06) :565-571
12345